For U.S. Healthcare Professionals Only

COTEMPLA XR-ODTTM (methylphenidate) extended-release orally disintegrating tablets, CII

For U.S. Healthcare Professionals Only

Now FDA Approved.
Coming Soon.

Cotempla XR-ODT™ is the first and only methylphenidate extended-release orally disintegrating tablet for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 to 17 years of age.

See Important Safety Information, including Boxed WARNING for abuse and dependence below.

Register to receive more information about Cotempla XR-ODT or download the Cotempla XR-ODT Press Release.